Candel Therapeutics Appoints Charles Schoch as Permanent CFO, Effective June 20, 2025

Candel Therapeutics, Inc.

Charles Schoch, interim CFO since Jan 2024, promoted to permanent CFO; base salary increased to $440,000, target bonus 40%.
Granted option to purchase 50,000 shares; 25% vests at one year, then ratably over 36 months.
Schoch previously served as VP Finance and Corporate Controller; led capital raise of ~$86M in Q4 2024.
Press release highlights upcoming BLA submission for CAN-2409 in localized prostate cancer.
No family relationships or arrangements with other parties disclosed.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Charles Schoch

Chief Financial Officer

CADL · Candel Therapeutics, Inc.

Effective: 2025-06-20
Filed: June 23, 2025, 7:59 PM ET

On June 20, 2025, the board of directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Charles Schoch as the Company’s Chief Financial Officer, effective June 20, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Charles Schoch was appointed as Chief Financial Officer at Candel Therapeutics, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On June 20, 2025, the board of directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Charles Schoch as the Company’s Chief Financial Officer, effective June 20, 2025

View on SEC.gov

Candel Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-144204

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.